Hiroshi Maruyama
Tracked across 1 events · 8 articles · First seen Aug 04, 2026 · Last active Aug 16, 2026
Live sentiment trends, attention charts, and prominence tracking available on the
Ergen Dashboard
Tech
Impact: Hiroshi Maruyama is the first author of the study, contributing to the development and validation of the therapy. His involvement may boost his research profile.
Aug 04, 2026 · 8 articles
ERGEN INTELLIGENCE
Track Hiroshi Maruyama live
Set up alerts, explore relationships, view sentiment trends, and monitor how events impact this entity in real time.
Open Dashboard